Research, News & Discoveries
-
Vanderbilt experts discuss colorectal cancer research progress in virtual event
by Marissa Shapiro Mar. 22, 2021, 9:00 AM In recognition of Colorectal Cancer Awareness Month, the School of Medicine Basic Sciences will host a panel discussion, “On the Cutting Edge: Research Toward a Cure for Colorectal Cancer,” on Tuesday, March 30, from 11… Read MoreMar. 25, 2021
-
Vanderbilt Institute of Chemical Biology’s 500th seminar to feature acclaimed biochemist and inventor Michael Marletta
by Marissa Shapiro Mar. 17, 2021, 9:00 AM By Miquéla Thornton Award-winning biochemist, inventor and educator Michael Marletta will speak about his nearly 50 years of studying nitric oxide—the body’s first line of defense against infection—during a seminar presented by the Vanderbilt… Read MoreMar. 22, 2021
-
Roden honored with Oscar B. Hunter Career Award in Therapeutics
Mar. 15, 2021, 9:26 AM by Leigh MacMillan Dan Roden, MD Dan Roden, MD, Senior Vice President for Personalized Medicine at Vanderbilt University Medical Center, received the Oscar B. Hunter Career Award in Therapeutics last week at the virtual annual meeting of the American Society… Read MoreMar. 16, 2021
-
New CRISPR screening technique developed at Vanderbilt leads to discovery of pathway that may be linked to cancer initiation
by Marissa Shapiro Mar. 10, 2021, 9:00 AM A new genome-wide CRISPR screening technique conducted by researchers at Vanderbilt University is offering new insights about how tumors in 80 to 90 percent of all cancers grow. Maria Fomicheva Ian Macara (Vanderbilt University) This novel… Read MoreMar. 10, 2021
-
Monoclonal antibody “cocktail” blocks COVID-19 variants: study
Mar. 4, 2021, 11:19 AM by Bill Snyder A monoclonal antibody “cocktail” developed at Vanderbilt University Medical Center to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published today in the journal Nature Medicine. That was one… Read MoreMar. 5, 2021
-
Chikungunya antibody identified by Crowe lab moves forward
Mar. 4, 2021, 8:54 AM by Bill Snyder Evotec, a drug company headquartered in Hamburg, Germany, has begun a phase 1 clinical trial of a monoclonal antibody against the chikungunya virus that was identified at Vanderbilt University Medical Center. This is the second monoclonal antibody against the debilitating tropical… Read MoreMar. 4, 2021
-
Steve Townsend wins Sloan Research Fellowship
by Ann Marie Deer Owens Feb. 16, 2021, 9:22 AM Assistant Professor of Chemistry Steven Townsend (Susan Urmy/Vanderbilt) Assistant Professor of Chemistry Steven D. Townsend, PhD’10, has been awarded a 2021 Sloan Research Fellowship, one of the highest honors for young… Read MoreMar. 3, 2021
-
Bordenstein elected to American Academy of Microbiology
by Ann Marie Deer Owens Mar. 2, 2021, 5:30 PM Seth Bordenstein (Vanderbilt University) Seth Bordenstein, Centennial Professor of Biological Sciences, has been elected to fellowship in the American Academy of Microbiology, the honorific leadership group within one of the… Read MoreMar. 3, 2021
-
Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics
by Marissa Shapiro Feb. 25, 2021, 8:00 AM A new partnership between Vanderbilt University’s Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will further research into new clinical treatments for multiple obesity syndromes. Jerod Denton Craig Lindsley… Read MoreFeb. 26, 2021
-
Despite limitations of pandemic, research continues in Basic Sciences
Feb. 24, 2021, 8:00 AM By Jenna Somers Vanderbilt researchers are prolific and resolute in their pursuit of transformative research and innovation. During the Research Ramp-up process, more than 3,000 Vanderbilt research personnel have returned to in-person research activities, while many others have continued remotely through perseverance and ingenuity. On… Read MoreFeb. 24, 2021